Sarepta Therapeutics, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/26/2026 | 110 | 0.0% | 5,092 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 78 | 0.0% | 4,024 | 9/30/2025 |
| 2025 Q2 | 7/21/2025 | 69 | 0.0% | 4,042 | 6/30/2025 |
| 2025 Q1 | 4/24/2025 | 227 | 0.0% | 3,223 | 3/31/2025 |
| 2024 Q4 | 1/27/2025 | 797 | 0.0% | 6,570 | 12/31/2024 |
| 2024 Q3 | 10/23/2024 | 747 | 0.0% | 6,002 | 9/30/2024 |
| 2024 Q2 | 7/30/2024 | 446 | 0.0% | 2,822 | 6/30/2024 |
| 2024 Q1 | 5/1/2024 | 12,131 | 0.0% | 90,945 | 3/31/2024 |
| 2023 Q4 | 1/24/2024 | 4,151 | 0.0% | 43,050 | 12/31/2023 |
| 2023 Q3 | 10/26/2023 | 11,621 | 0.0% | 95,865 | 9/30/2023 |
| 2023 Q2 | 8/10/2023 | 10,428 | 0.0% | 91,102 | 6/30/2023 |
| 2023 Q1 | 5/4/2023 | 12,744 | 0.0% | 92,463 | 3/31/2023 |
| 2022 Q4 | 2/9/2023 | 11,453 | 0.0% | 88,383 | 12/31/2022 |
| 2022 Q3 | 11/10/2022 | 13,876 | 0.0% | 125,530 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 8,517 | 0.0% | 113,622 | 6/30/2022 |
| 2022 Q1 | 5/10/2022 | 10,421 | 0.0% | 133,403 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 13,973 | 0.0% | 155,171 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 16,221 | 0.0% | 175,397 | 9/30/2021 |
| 2021 Q2 | 8/11/2021 | 11,037 | 0.0% | 141,973 | 6/30/2021 |
| 2021 Q1 | 5/13/2021 | 4,197 | 0.0% | 56,303 | 3/31/2021 |
| 2020 Q4 | 2/10/2021 | 5,483 | 0.0% | 32,160 | 12/31/2020 |
| 2020 Q3 | 11/12/2020 | 3,291 | 0.0% | 23,436 | 9/30/2020 |
| 2020 Q2 | 8/11/2020 | 2,781 | 0.0% | 17,344 | 6/30/2020 |
| 2020 Q1 | 5/12/2020 | 1,497 | 0.0% | 15,298 | 3/31/2020 |
| 2019 Q4 | 2/12/2020 | 1,664 | 0.0% | 12,898 | 12/31/2019 |